|
Pérez-Sánchez I, Romero-Puche AJ, García-Molina Sáez E, Sabater-Molina M, López-Ayala JM, Muñoz-Esparza C, López-Cuenca D, de la Morena G, Castro-García FJ, Gimeno-Blanes JR. Factors Influencing the Phenotypic Expression of Hypertrophic Cardiomyopathy in Genetic Carriers. Rev Esp Cardiol (Engl Ed). 2018 Mar;71(3):146-154. doi: 10.1016/j.rec.2017.06.002. Epub 2017 Jul 4. English, Spanish. PubMed PMID: 28687478.
AÑO: 2018; IF: 5.126
|
28687478
|
Pérez-Sánchez I, Sabater-Molina M, Muñoz-Esparza C, Gimeno-Blanes JR. Phenotype-modifying Factors in Hypertrophic Cardiomyopathy. Response. Rev Esp Cardiol (Engl Ed). 2018 Sep;71(9):770-771. doi: 10.1016/j.rec.2018.04.023. Epub 2018 Jun 25. English, Spanish. PubMed PMID: 29954718.
AÑO: 2018; IF: 5.126
|
|
Muñoz-Esparza C, Zorio E, Domingo Valero D, Peñafiel-Verdú P, Sánchez-Muñoz JJ, García-Molina E, Sabater M, Navarro M, San-Román I, Pérez I, Santos JJ, Cabañas-Perianes V, Valdés M, Pascual D, García-Alberola A, Gimeno Blanes JR. Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome. Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):907-914. doi: 10.1016/j.rec.2017.01.006. Epub 2017 Feb 21. English, Spanish. PubMed PMID: 28233664.
AÑO: 2017; IF: 5.166
|
|
López-Cuenca D, Muñoz-Esparza C, Navarro Peñalver M, García Alberola A, Gimeno Blanes JR. Hypertrophic or hypertensive cardiomyopathy? Int J Cardiol. 2016 Jan 15;203:891-2. doi: 10.1016/j.ijcard.2015.11.071. Epub 2015 Nov 10. PubMed PMID: 26609686.
AÑO: 2016; IF: 6.189
|
|
San Román I, Navarro M, Martínez F, Albert L, Polo L, Guardiola J, García-Molina E, Muñoz-Esparza C, López-Ayala JM, Sabater-Molina M, Gimeno JR. Unclassifiable arrhythmic cardiomyopathy associated with Emery-Dreifuss caused by a mutation in FHL1. Clin Genet. 2016 Aug;90(2):171-6. doi: 10.1111/cge.12760. Epub 2016 Mar 23. PubMed PMID: 26857240.
AÑO: 2016; IF: 3.326
|